Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Amortization of Deferred Charges (2021 - 2023)

AVITA Medical (RCEL) has disclosed Amortization of Deferred Charges for 2 consecutive years, with $86000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Amortization of Deferred Charges rose 1.18% year-over-year to $86000.0, compared with a TTM value of $341000.0 through Dec 2023, up 34.25%, and an annual FY2023 reading of $341000.0, up 0.89% over the prior year.
  • Amortization of Deferred Charges was $86000.0 for Q4 2023 at AVITA Medical, up from $85000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $86000.0 in Q4 2023 and bottomed at $84000.0 in Q2 2022.